Pharmacognosy Communications,2019,9,2,38.
Published:April 2019


Ian Edwin Cock1,2,*

1Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

2School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.


Dear readers and authors,

I am pleased to bring you Volume 9, Issue 2 of Pharmacognosy Communications. In this issue we present new research reports examining the pharmacognosy of several important medicinal plants including an ethnobotanbical review of medicinal plants from the Ngong Forest in Kenya. This study also screened these plants against several pathogenic diseases and determined their antioxidant contents. Two other studies examined the antibacterial properties of the Australian plant species Callistemon linearis Schrad. and J.C. Wendl. and Mischarytera lauteriana (F.M. Bailey) respectively. Similarly, another study examined the antimicrobial and antioxidant activities of Prosopis cineraria, an important plant in Indian medicinal systems. The final study included in this issue reports that Piper novae-hollandiae Miq. leaf extracts lack antibacterial activity. Whilst this is a negative result, it is interesting as closely related plant species often share similar secondary metabolites and bioactivities. Indeed, the genus Piper has a long history of medicinal usage in many areas of the world and many Piper spp. have therapeutic properties, including antibacterial bioactivities. Thus, this species was considered a good candidate for antibacterial activity screening. The publication of negative results such as this are important so that valuable time and resources are not wasted by other groups repeating these tests. Our regular features are also continued in this issue. The Janus Corner presents short notifications of interest to readers of Pharmacognosy Communications. Read more...


Cite This Article

Vancouver Style :: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(2):38.  (169.59 KB)
MLA Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(2):38.  (169.59 KB)
CSE Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(2):38.  (169.59 KB)
APA Style: Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(2):38.  (169.59 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.